Home › Clinical Tools › PAGE-B

🧫 PAGE-B HCC Risk (On Antivirals)

UseWhen to use: CHB patients on nucleos(t)ide analogues.

Loading calculator…

Strata≤9 low / 10–17 intermediate / ≥18 high (Caucasian derivation).

LimitsWhen not to use: untreated CHB without adaptation. · Pitfall: applying cutoffs blindly to all ethnicities. · Modified PAGE-B exists for Asia.

SourcePapatheodoridis G et al. PAGE-B

Runs locally in your browser (no PHI uploaded). For licensed clinicians — not a substitute for clinical judgement.
Stored on this device for revisit reminders

This-shift next steps

After scoring: open the scene pack, peer scores, and the matching pathway. Local reference — no HIS write.

Score + version; reference only — not a substitute for care · no HIS write

Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.

Methodology · worked example, guidelines & full notes
Clinical takeaway

Age+sex+PLT.

When to use

When to use: CHB patients on nucleos(t)ide analogues.

How it works

Age 0–10 + sex 0/5 + platelets 0/6/9 (max 25).

Key points

  • Age+sex+PLT.
  • NA-treated CHB.
  • Next: surveillance intensity.

References

  • Papatheodoridis G et al. PAGE-B

Worked calculation

The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.

Age40–49 (+4)
SexFemale (0)
Platelets (×10⁹/L)100–199 (+6)

→PAGE-B10/25

  • Cue:10–17 — intermediate risk band
Age16–29 (0)
SexFemale (0)
Platelets (×10⁹/L)≥200 (0)

→PAGE-B0/25

  • Cue:≤9 — low risk band in Caucasian NA-treated derivation
Verification & sources · governance
FAQ

Frequently asked questions

Does PAGE-B HCC Risk (On Antivirals) upload patient data? Where is it calculated?
Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
How is PAGE-B HCC Risk (On Antivirals) calculated in practice? Can you show a worked example?
Inputs: Age 40–49 (+4), Sex Female (0), Platelets (×10⁹/L) 100–199 (+6) → Result: PAGE-B 10 /25(Cue: 10–17 — intermediate risk band) Inputs: Age 16–29 (0), Sex Female (0), Platelets (×10⁹/L) ≥200 (0) → Result: PAGE-B 0 /25(Cue: ≤9 — low risk band in Caucasian NA-treated derivation)
Related tools